﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Generated by www.ashp.org on Sat, 07 Nov 2009 16:03:09--><rss version="2.0"><channel><title>ASHP Health-System Pharmacy News</title><link>http://www.ashp.org/Import/NEWS/HealthSystemPharmacyNews.aspx</link><description>ASHP Health-System Pharmacy News</description><language>en-us</language><copyright>Copyright2009 ASHP</copyright><docs>http://blogs.law.harvard.edu/tech/rss/</docs><lastBuildDate>Sat, 07 Nov 2009 16:03:09</lastBuildDate><image><url>http://www.ashp.org/images/ashprss.gif</url><title>ASHP</title><link>http://www.ashp.org/</link><width>57</width><height>34</height></image><item><title><![CDATA[Systemic Therapy Approved To Treat Cutaneous Lymphoma]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3211</link><description><![CDATA[Gloucester Pharmaceuticals announced Thursday that FDA approved the marketing of romidepsin, or Istodax, for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have already received at least one systemic therapy for the disease.]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3211</guid><pubDate>Fri, 06 Nov 2009</pubDate></item><item><title><![CDATA[Book Correction Notice for 'Handbook on Injectable Drugs, 15th Edition']]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3210</link><description><![CDATA[There is an error in the monograph for Remifentanil Hydrochloride in Handbook on Injectable Drugs, 15th Edition, published by ASHP and edited by Lawrence A. Trissel.]]></description><category>ASHPNews</category><author /><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3210</guid><pubDate>Thu, 05 Nov 2009</pubDate></item><item><title><![CDATA[American Regent Recalls All Ketorolac Vials]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3209</link><description><![CDATA[American Regent Inc. on November 3 announced a recall of all of the company's 15-mg/mL ketorolac tromethamine injection for the same reason it recalled all 30-mg/mL vials in mid-October: "the potential that particulates from crystallization may be present."]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3209</guid><pubDate>Wed, 04 Nov 2009</pubDate></item><item><title><![CDATA[CDC Stockpile Releases Remaining Oseltamivir Liquid]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3208</link><description><![CDATA[All of the remaining pediatric oseltamivir liquid in the Strategic National Stockpile (SNS) is being released to the states in response to widespread reports of influenza, Centers for Disease Control and Prevention (CDC) Director Thomas Frieden told reporters today.]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3208</guid><pubDate>Fri, 30 Oct 2009</pubDate></item><item><title><![CDATA[Qualitest Recalls All Accusure Insulin Syringes]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3207</link><description><![CDATA[Qualitest Pharmaceuticals Inc. is recalling all Accusure insulin syringes because some may have a needle that separates from the syringe, according to an&#160;announcement circulated today by FDA.]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3207</guid><pubDate>Tue, 27 Oct 2009</pubDate></item><item><title><![CDATA[Ofatumumab Approved for Advanced CLL]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3206</link><description><![CDATA[Ofatumumab, a cytolytic CD-20 monoclonal antibody product from GlaxoSmithKline and Genmab A/S, has been licensed for the treatment of chronic lymphocytic leukemia (CLL) in patients whose cancer does not respond to other chemotherapy, FDA announced late yesterday.]]></description><category>ASHP Action Line</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3206</guid><pubDate>Tue, 27 Oct 2009</pubDate></item><item><title><![CDATA[American Regent Recalls All 30-mg/mL Ketorolac Vials]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3205</link><description><![CDATA[American Regent Inc. on October 16 recalled all lots of the company's 30-mg/mL ketorolac tromethamine injection because of the presence of "particulate matter in conjunction with crystallization," according to a press release circulated today by FDA.]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3205</guid><pubDate>Wed, 21 Oct 2009</pubDate></item><item><title><![CDATA[New Angiogenesis Inhibitor Approved for Renal Cell Carcinoma]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3204</link><description><![CDATA[FDA and GlaxoSmithKline on Monday announced the approval of pazopanib, or Votrient, for the treatment of advanced renal cell carcinoma.]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3204</guid><pubDate>Tue, 20 Oct 2009</pubDate></item><item><title><![CDATA[Flu Season Could Be Long, Hard, CDC Says]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3203</link><description><![CDATA[The Centers for Disease Control and Prevention (CDC) today released new data about people recently hospitalized with 2009 H1N1 influenza virus infections and said the agency is preparing for a long, difficult flu season.]]></description><category>ASHP Action Line</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3203</guid><pubDate>Tue, 20 Oct 2009</pubDate></item><item><title><![CDATA[FDA Approves Cervarix]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3202</link><description><![CDATA[FDA on Friday approved a license from GlaxoSmithKline to market Cervarix, a vaccine designed to protect against cancers caused by infection with human papillomavirus (HPV) types 16 or 18.]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3202</guid><pubDate>Mon, 19 Oct 2009</pubDate></item></channel></rss>